RESPONSE BIOMEDICAL'S RAMP SYSTEM RECEIVES MARKET CLEARANCE IN CHINA

Response Biomedical has announced that the RAMP Reader and three RAMP Cardiac Marker Tests have received regulatory clearance in China from the State Food and Drug Administration (SFDA). Effective immediately, O&D Biotechnology, the company's exclusive distributor in China, is marketing rapid quantitative RAMP tests for detecting troponin I, CK-MB and myoglobin to assist in the rapid diagnosis of heart attack or acute myocardial infarction.

Canada NewsWire (http://www.newswire.ca/en/releases/archive/January2005/05/c9814.html)